1 CLINICAL STUDY AGREEMENT SMLOUVA O KLINICKÉ STUDII This Clinical Study Agreement (“Agreement”) is made and entered into a
Trial record 1 of 1 for: AC220-A-U302 Quizartinib With Standard of Care Chemotherapy and as Maintenance Therapy in Patients W
TITULO CÓDIGO PROTOCOLO DEL ENSAYO SERVICIO Estudio abierto y multicéntrico en fase III de Brigatinib (AP26113) frente a Crizo
Leukemia Lymphoma - Hodgkin Stem Cell Transplant Hematologic / Bone Marrow Diseases Brain and Nervous System Thoracic/Head and N
CLINICAL STUDY AGREEMENT SMLOUVA O KLINICKÉ STUDII This Clinical Study Agreement (“Agreement”) is made and entered into as
![Clinical Trials, Study Results and Plain Language Results Summaries - Clinical Trials - Research & Development - Daiichi Sankyo Clinical Trials, Study Results and Plain Language Results Summaries - Clinical Trials - Research & Development - Daiichi Sankyo](https://www.daiichisankyo.com/files/news/ourstories/images/2204_Patientvoices_GissooD/pcm_gissoo_kv.jpg)